Action Point Financial Planning’s Gilead Sciences GILD Stock Holding History

Action Point Financial Planning’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127K	Buy	+1,014	New	+$134K	0.01%	534

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Action Point Financial Planning's GILD Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,014 shares worth $127K. The stake represents 0.01% of the portfolio and ranks #534 among its holdings.

2,264 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Action Point Financial Planning held 1,014 shares of Gilead Sciences worth $127K as of Q2 2026.
Gilead Sciences was a new Action Point Financial Planning position in Q2 2026.
Gilead Sciences made up 0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #534 holding.
2,264 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.